Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Tandem Duplications of the UBTF gene in Adult AML: A Rare but Recurrent Alteration Associated with Myelodysplasia and Poor Outcome

Blood (2022) 140 (Supplement 1): 6262–6264.

https://doi.org/10.1182/blood-2022-164702

Published: 2022

Journal Articles

Application of AI-Based Analytical Approaches for Multiplex Immunophenotyping of SF3B1 -Mutant Myelodysplastic Syndrome Subtype

Susann Winter, Jessica A. Timms, Uta Oelschlaegel, Antje Tunger, Claire N. Harrison, Desmond Choy, Marc Schmitz, Uwe Platzbecker, Shahram Kordasti

Blood (2021) 138 (Supplement 1): 1512.

https://doi.org/10.1182/blood-2021-149706

Published: 2021

Journal Articles

Targeting the Inflammatory Niche in MDS By Tasquinimod Restores Hematopoietic Support and Suppresses Immune-Checkpoint Expression in Vitro

Manja Wobus, Ekaterina Balaian, Uta Oelschlaegel, Russell Towers, Kristin Möbus, Ivonne Habermann, Rebekka Wehner, Friedrich Stölzel, Triantafyllos Chavakis, Marie Törngren, Helena Eriksson, Uwe Platzbecker, Christoph Röllig, Martin Bornhäuser, Katja Sockel

Blood (2021) 138 (Supplement 1): 2596.

https://doi.org/10.1182/blood-2021-150455

Published: 2021

Journal Articles

Independent Prognostic Value of Flow Cytometry (FCM) in Myelodysplastic Syndromes (MDS) - Composition of a Prognostic FCM-Score for Overall Survival

Uta Oelschlaegel, Aida Santaolalla, Jessica A. Timms, Susann Winter, Katja Sockel, Martin Bornhäuser, Farzin Farzaneh, Claire N. Harrison, Theresia M. Westers, Arjan van de Loosdrecht, Mieke Van Hemelrijck, Uwe Platzbecker, Shahram Kordasti

Blood (2021) 138 (Supplement 1): 2603.

https://doi.org/10.1182/blood-2021-146367

Published: 2021

Journal Articles

Multicenter Prospective Evaluation of Diagnostic Potential of Flow Cytometric Aberrancies in Myelodysplastic Syndromes

Blood (2021) 138 (Supplement 1): 3995.

https://doi.org/10.1182/blood-2021-152298

Published: 2021

Journal Articles

Machine Learning Approach Identifies Independent Prognostic Value of Flow Cytometry (FCM) in Myelodysplastic Syndromes (MDS)

Uta Oelschlaegel, PhD, Kevin Blighe, PhD, Susann Winter, PhD, Katja Sockel, MD, Martin Bornhäuser, MD, Shahram Kordasti, MD PhD, Uwe Platzbecker

Blood (2019) 134 (Supplement_1): 4251.

https://doi.org/10.1182/blood-2019-128042

Published: 2019

Journal Articles

Impairment of the Stromal SDF-1-Mediated Hematopoietic Support By GDF-11 in MDS Is Rescued By Luspatercept

Manja Wobus, Anna Mies, Nandini Asokan, Uta Oelschlaegel, Susann Winter, Martina Rauner, PhD, Lorenz Hofbauer, Martin Bornhäuser, Uwe Platzbecker

Blood (2018) 132 (Supplement 1): 939.

https://doi.org/10.1182/blood-2018-99-114536

Published: 2018

Journal Articles

Anti-CD123 Targeted Therapy with Talacotuzumab in Advanced MDS and AML after Failing Hypomethylating Agents - Final Results of the Samba Trial

Anne Sophie Kubasch, MD, Freya Schulze, Katharina S. Götze, MD, Jan Krönke, MD, Katja Sockel, MD, Jan Moritz Middeke, MD, Fatiha Chermat, Silke Gloaguen, MSc, Martin Puttrich, Carmen Weigt, Katja Jersemann, Pierre Fenaux, MD PhD, Richard F. Schlenk, MD, Aristoteles Giagounidis, Lionel Ades, MD PhD, Anna Mies, Uta Oelschlaegel, Uwe Platzbecker

Blood (2018) 132 (Supplement 1): 4045.

https://doi.org/10.1182/blood-2018-99-113112

Published: 2018

Journal Articles

Prospective Comparative Evaluation of Flow Cytometric Scores Regarding the Sensitivity and Specificity As Well As Prognosis in 616 Patients with Proven or Suspected MDS

Uta Oelschlaegel, Lorenz Oelschlaeger, Brigitte Mohr, Katja Sockel, MD, Martin Bornhäuser, MD, Uwe Platzbecker

Blood (2018) 132 (Supplement 1): 1816.

https://doi.org/10.1182/blood-2018-99-111454

Published: 2018

Journal Articles

Flow Cytometric Response Monitoring in MDS with Del(5q) Using a Simple 5-Parameter-Score - an Elnet Imds-Flow Experience

Uta Oelschlaegel, PhD, Theresia M. Westers, PhD, Brigitte Mohr, PhD, Ulrika Johansson, PhD, Dolores Subira, PhD, Gerhard Ehninger, MD, Martin Bornhäuser, MD, Arjan A van de Loosdrecht, MD PhD, Uwe Platzbecker, MD

Blood (2016) 128 (22): 3179.

https://doi.org/10.1182/blood.V128.22.3179.3179

Published: 2016

Journal Articles

Implementation of Diagnostic Flow Cytometry Allows for the Dissection of Age Related Loss of Y Chromosome from Myelodysplastic Syndrome (MDS)

Uta Oelschlaegel, PhD, Brigitte Mohr, PhD, Katja Sockel, MD, Gerhard Ehninger, MD, Martin Bornhäuser, MD, Uwe Platzbecker

Blood (2016) 128 (22): 5531.

https://doi.org/10.1182/blood.V128.22.5531.5531

Published: 2016

Journal Articles

Diagnostic Application of Immunophenotypic Analysis of Erythroid Dysplasia in Myelodysplastic Syndromes. a Report on Behalf of the European Leukemianet-IMDS-Flow Cytometry Working Group

Theresia M Westers, PhD, Eline MP Cremers, MD, Uta Oelschlaegel, PhD, Ulrika Johansson, PhD, Peter Bettelheim, MD, Birgit Witte, PhD, Matteo G Della Porta, MD, Wolfgang Kern, MD, Arjan van de Loosdrecht, MDPhD

Blood (2014) 124 (21): 1914.

https://doi.org/10.1182/blood.V124.21.1914.1914

Published: 2014

Journal Articles

Selective Expansion of Regulatory T-Cells during Lenalidomid Treatment of MDS with Isolated Deletion 5q

Martin Wermke, MD, Claudia Schuster, Claudia Schönefeldt, Sebastian Tuve, MD, Gerhard Ehninger, MD, Detlef Haase, Ulrich Germing, MD, Martin Bornhäuser, MD, Uta Oelschlaegel, PhD, Malte von Bonin, MD, Uwe Platzbecker, MD

Blood (2014) 124 (21): 4654.

https://doi.org/10.1182/blood.V124.21.4654.4654

Published: 2014

Journal Articles

A Distinct Immunophenotypic Profile Of Del(5q) MDS Allows For Fast Monitoring Of Response To Treatment With Lenalidomide Or Azacitidine

Uta Oelschlaegel, PhD, Brigitte Mohr, PhD, Michael Kramer, PhD, Stefani Parmentier, MD, Katja Sockel, MD, Christian Thiede, MD, Martin Bornhäuser, MD, Gerhard Ehninger, MD, Uwe Platzbecker, MD, PhD

Blood (2013) 122 (21): 2780.

https://doi.org/10.1182/blood.V122.21.2780.2780

Published: 2013

Journal Articles

POTENTIAL ROLE of 8-COLOR FLOW CYTOMETRY for CHARACTERIZATION of MDS with Del(5q) ABNORMALITIES

Uta Oelschlaegel, PhD, Katja Sockel, MD, Brigitte Mohr, Christian Thiede, MD, Gerhard Ehninger, MD, Uwe Platzbecker, MD

Blood (2011) 118 (21): 5020.

https://doi.org/10.1182/blood.V118.21.5020.5020

Published: 2011

Journal Articles

The Incidence of Central Nervous System Involvement in AML: A SAL-Tor Vergata Analysis

Nael Alakel, MD, Maria Ilaria Del Principe, Friedrich Stölzel, MD, Brigitte Mohr, Uta Oelschlaegel, PhD, Sergio Amadori, MD, Gerhard Ehninger, MD, Adriano Venditti, M.D., Markus Schaich, MD

Blood (2011) 118 (21): 4236.

https://doi.org/10.1182/blood.V118.21.4236.4236

Published: 2011

Journal Articles

Prophylactic transfer of BCR-ABL–, PR1-, and WT1-reactive donor T cells after T cell–depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemia

Martin Bornhäuser, Christian Thiede, Uwe Platzbecker, Alexander Kiani, Uta Oelschlaegel, Jana Babatz, Doris Lehmann, Kristina Hölig, Jörgen Radke, Sebastian Tuve, Martin Wermke, Rebekka Wehner, Hanka Jähnisch, Michael P. Bachmann, E. Peter Rieber, Johannes Schetelig, Gerhard Ehninger, Marc Schmitz

Blood (2011) 117 (26): 7174–7184.

https://doi.org/10.1182/blood-2010-09-308569

Published: 2011

Journal Articles

A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial

Blood (2010) 116 (6): 971–978.

https://doi.org/10.1182/blood-2010-01-267302

Published: 2010

Journal Articles

Prior Treatment with Alemtuzumab Interferes with T-Cell Engraftment After Allogeneic Stem Cell Transplantation in Patients with Chronic Lymphocytic Leukemia.

Johannes Schetelig, Christian Thiede, Alexander Kiani, Uwe Platzbecker, Uta Oelschlaegel, Matthias Haenel, Gaby Geissler, Rainer Schwerdtfeger, MD, Karin Kolbe, MD, Martin Kaufmann, Matthias Zeis, MD, Kerstin Schaefer-Eckart, MD, Wolfgang Siegert, MD, PhD, Gerhard Ehninger

Blood (2009) 114 (22): 3351.

https://doi.org/10.1182/blood.V114.22.3351.3351

Published: 2009

Journal Articles

Flow Cytometric Detection of Minimal Residual Disease One Year Post Allogeneic Stem Cell Transplantation Predicts Outcome in Patients with B-CLL.

Uta Oelschlaegel, Martin Bornhäuser, Alexander Kiani, Uwe Platzbecker, Christoph Röllig, Martin Wermke, Christian Thiede, Gerhard Ehninger, Johannes Schetelig

Blood (2009) 114 (22): 202.

https://doi.org/10.1182/blood.V114.22.202.202

Published: 2009

NARROW

Tandem Duplications of the UBTF gene in Adult AML: A Rare but Recurrent Alteration Associated with Myelodysplasia and Poor Outcome

Application of AI-Based Analytical Approaches for Multiplex Immunophenotyping of SF3B1 -Mutant Myelodysplastic Syndrome Subtype

Targeting the Inflammatory Niche in MDS By Tasquinimod Restores Hematopoietic Support and Suppresses Immune-Checkpoint Expression in Vitro

Independent Prognostic Value of Flow Cytometry (FCM) in Myelodysplastic Syndromes (MDS) - Composition of a Prognostic FCM-Score for Overall Survival

Multicenter Prospective Evaluation of Diagnostic Potential of Flow Cytometric Aberrancies in Myelodysplastic Syndromes

Machine Learning Approach Identifies Independent Prognostic Value of Flow Cytometry (FCM) in Myelodysplastic Syndromes (MDS)

Impairment of the Stromal SDF-1-Mediated Hematopoietic Support By GDF-11 in MDS Is Rescued By Luspatercept

Anti-CD123 Targeted Therapy with Talacotuzumab in Advanced MDS and AML after Failing Hypomethylating Agents - Final Results of the Samba Trial

Prospective Comparative Evaluation of Flow Cytometric Scores Regarding the Sensitivity and Specificity As Well As Prognosis in 616 Patients with Proven or Suspected MDS

Flow Cytometric Response Monitoring in MDS with Del(5q) Using a Simple 5-Parameter-Score - an Elnet Imds-Flow Experience

Implementation of Diagnostic Flow Cytometry Allows for the Dissection of Age Related Loss of Y Chromosome from Myelodysplastic Syndrome (MDS)

Diagnostic Application of Immunophenotypic Analysis of Erythroid Dysplasia in Myelodysplastic Syndromes. a Report on Behalf of the European Leukemianet-IMDS-Flow Cytometry Working Group

Selective Expansion of Regulatory T-Cells during Lenalidomid Treatment of MDS with Isolated Deletion 5q

A Distinct Immunophenotypic Profile Of Del(5q) MDS Allows For Fast Monitoring Of Response To Treatment With Lenalidomide Or Azacitidine

POTENTIAL ROLE of 8-COLOR FLOW CYTOMETRY for CHARACTERIZATION of MDS with Del(5q) ABNORMALITIES

The Incidence of Central Nervous System Involvement in AML: A SAL-Tor Vergata Analysis

Prophylactic transfer of BCR-ABL–, PR1-, and WT1-reactive donor T cells after T cell–depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemia

A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial

Prior Treatment with Alemtuzumab Interferes with T-Cell Engraftment After Allogeneic Stem Cell Transplantation in Patients with Chronic Lymphocytic Leukemia.

Flow Cytometric Detection of Minimal Residual Disease One Year Post Allogeneic Stem Cell Transplantation Predicts Outcome in Patients with B-CLL.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only